GFAP mouse monoclonal antibody, clone OTI1H7
| Applications | ELISA |
| Reactivities | Human |
Assay Kits
GFAP mouse monoclonal antibody, clone OTI4D12
| Applications | ELISA |
| Reactivities | Human |
GFAP mouse monoclonal antibody, clone OTI4B5
| Applications | ELISA |
| Reactivities | Human |
GFAP mouse monoclonal antibody, clone OTI2D4
| Applications | ELISA |
| Reactivities | Human |
GFAP mouse monoclonal antibody, clone OTI1F4
| Applications | ELISA |
| Reactivities | Human |
GFAP mouse monoclonal antibody, clone OTI3E8
| Applications | ELISA |
| Reactivities | Human |
IL-17A mouse monoclonal antibody, clone OTI2B7
| Applications | ELISA |
| Reactivities | Human |
GFAP mouse monoclonal antibody, clone OTI3F3
| Applications | ELISA |
| Reactivities | Human |
IL-17A mouse monoclonal antibody, clone OTI3H2
| Applications | ELISA |
| Reactivities | Human |
IL-17A mouse monoclonal antibody, clone OTI3H3
| Applications | ELISA |
| Reactivities | Human |
IL-17A mouse monoclonal antibody, clone OTI13E7
| Applications | ELISA |
| Reactivities | Human |
IL-17A mouse monoclonal antibody, clone OTI9C2
| Applications | ELISA |
| Reactivities | Human |
IL-17A mouse monoclonal antibody, clone OTI13B1
| Applications | ELISA |
| Reactivities | Human |
IL-17A mouse monoclonal antibody, clone OTI9D4
| Applications | ELISA |
| Reactivities | Human |
IL-17A mouse monoclonal antibody, clone OTI13F3
| Applications | ELISA |
| Reactivities | Human |
活动过滤器
优化搜索结果
Target Symbol
- PGP9.5 (120)
- NGAL (111)
- IL6 (104)
- ST2 (104)
- GFAP (100)
- S100A8/A9 (87)
- IL17 (84)
- D-DIMER (83)
- MYELOPEROXIDASE (78)
- SERUM AMYLOID A (66)
- MYBPC3 (63)
- FABP3 (60)
- REG1 ALPHA (60)
- NEUROFILAMENT (48)
- IGG4 (38)
- B7-1 (20)
- PD1 (20)
- S100 BETA (20)
- B RAF (15)
- PON1 (15)
- PSMA (15)
- BETA 2 MICROGLOBULIN (10)
- MSMB (10)
- PD-L1 (10)
- S100A1 (10)
- SERPINB3 (10)
- MAGEA3 (2)
- S100A8/S100A9 (2)
- VIMENTIN (2)
- CA12 (1)
Applications
Antibody Hosts
Knockout (KO) Validation
Conjugates
Isotypes
Clonalities
Assay Types
Families
Pathways
- Cytokine-cytokine receptor interaction (188)
- Hypertrophic cardiomyopathy (HCM) (167)
- Graft-versus-host disease (124)
- Toll-like receptor signaling pathway (124)
- Parkinson's disease (120)
- Pathways in cancer (119)
- Cytosolic DNA-sensing pathway (104)
- Hematopoietic cell lineage (104)
- Jak-STAT signaling pathway (104)
- NOD-like receptor signaling pathway (104)
- Prion diseases (104)
- Dilated cardiomyopathy (63)
- PPAR signaling pathway (60)
- Cell adhesion molecules (CAMs) (50)
- Amyotrophic lateral sclerosis (ALS) (48)
- Allograft rejection (20)
- Autoimmune thyroid disease (20)
- Systemic lupus erythematosus (20)
- T cell receptor signaling pathway (20)
- Type I diabetes mellitus (20)
- Viral myocarditis (20)
- Acute myeloid leukemia (15)
- Bladder cancer (15)
- Chemokine signaling pathway (15)
- Chronic myeloid leukemia (15)
- Colorectal cancer (15)
- Endometrial cancer (15)
- ErbB signaling pathway (15)
- Focal adhesion (15)
- Glioma (15)
- Insulin signaling pathway (15)
- Long-term depression (15)
- Long-term potentiation (15)
- MAPK signaling pathway (15)
- Melanoma (15)
- Metabolic pathways (15)
- Natural killer cell mediated cytotoxicity (15)
- Neurotrophin signaling pathway (15)
- Non-small cell lung cancer (15)
- Pancreatic cancer (15)
- Progesterone-mediated oocyte maturation (15)
- Prostate cancer (15)
- Regulation of actin cytoskeleton (15)
- Renal cell carcinoma (15)
- Thyroid cancer (15)
- Vascular smooth muscle contraction (15)
- mTOR signaling pathway (15)
- Antigen processing and presentation (10)
- Nitrogen metabolism (1)
Assay Platforms
__Matched ELISA Pair
- TA600453 (1)
- TA600550 (1)
- TA600552 (1)
- TA600553 (1)
- TA600555, TA600556 (1)
- TA600555, TA700556 (1)
- TA600556, TA700556 (1)
- TA600557 (1)
- TA600558 (1)
- TA600559 (1)
- TA600560 (1)
- TA600574 (1)
- TA700040 (1)
- TA700390 (1)
- TA700455, TA700452 (1)
- TA700550 (1)
- TA700552 (1)
- TA700553 (1)
- TA700554, TA600554 (1)
- TA700554, TA700555 (1)
- TA700555, TA600554 (1)
- TA700557 (1)
- TA700559 (1)
- TA700560 (1)
